University of Tennessee, Memphis   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Memphis TN United States (1911)

Organization Overview

First Clinical Trial
2000
NCT00005675
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

UTHSC | UTHSC, Memphis, TN

Active Ingredients

Drugs in Phase 4 Trials (1)

folic acid (1 trial)

Drugs in Phase 2 Trials (1)

bovine type i collagen (1 trial)

Drugs in Other Trials (1)

human milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Connective Tissue Diseases (Phase 2)

Inflammatory Bowel Diseases (Phase 4)

Intestinal Diseases (Phase 4)

Scleroderma, Diffuse (Phase 2)

Scleroderma, Localized (Phase 2)

Scleroderma, Systemic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3